Application of Extended Care in Antiviral Therapy for Elderly Patients with Acquired Immunodeficiency Syndrome

Objective To explore the effect of extended care on improving the compliance, efficacy and quality of life of antiviral therapy in elderly patients with acquired immunodeficiency syndrome (AIDS) . Methods A total of 200 elderly patients with acquired immunodeficiency syndrome who received initial antiviral therapy in Beijing You'an Hospital from January 2015 to December 2021 were selected as the study subjects and randomly divided into the control group and the test group according to the lottery method, with 100 cases in each group. The control group received routine care and health education, and the experimental group was given extended care on the basis of the control group. After 1 year of follow-up, medication compliance, efficacy, and quality of life were compared between the two groups. Results During 1-year follow-up, the medication compliance of the test group was higher than that in the control group, and the difference was statistically significant (P < 0.05); the increase of CD4+ T lymphocyte count in the test group was higher than that in the control group (P < 0.05); the viral load was undetectable after treatment in both groups. The scores of physical domain, psychological domain, social relationship domain and environmental domain of quality of life in the test group were higher than those in the control group, and the differences were statistically significant (P < 0.05) . Conclusion Extended care is beneficial to improve the medication compliance and antiviral effect of elderly patients with acquired immunodeficiency syndrome, and improve the quality of life of patients. It is worthy of clinical promotion and application.